Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells

European Journal of Pharmacology

Volumn 372, Issue 3, 1999, Pages 287-295

  Kochi, S ^a   Takanaga, H ^a   Matsuo, H ^a   Naito, M ^a   Tsuruo, T ^a   Sawada, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Cyclosporin A; Cytotoxicity; Encephalopathy; P glycoprotein; Tacrolimus

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; TACROLIMUS; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN DISEASE; CELL DAMAGE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCYTOSIS;

EID: 0033064431     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00247-2     Document Type: Article

References (38)

1. D Adu J Michael J Turney P McMaster Hyperkalemia in cyclosporin-treated renal allograft recipients Lancet 2 1983 370 371
2. B.A Appignani R.A Bhadelia S.C Blacklow S.F Roland R.B Freeman Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity Am. J. Roentgenol. 166 1996 683 688
3. O.A Bessey O.H Lowry M.J Brock A method for the rapid determination of alkaline phosphatase with five cubic: millimeters of serum J. Biol. Chem. 164 1946 321 329
4. Borel, J.F., Kis, Z.L., Beveridge, T., 1995. The history of the discovery and development of cyclosporine (SandimmuneR). In: Merluzzi, V.J., Adams, J. (Eds.), The Search of Anti Inflammatory Drugs. Birkhäuser, Boston, pp. 27–63.
5. D.J Brat A.J Windebank S Brimijoin Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma J. Pharmacol. Exp. Ther. 262 1992 803 810
6. P.C De Groen A.J Aksamit J Rakela G.S Forbes R.A.F Krom Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol N. Engl. J. Med. 317 1987 861 866
7. M.M.S Del Pino R.A Hawkins D.R Peterson Neutral amino acid transport by the blood–brain barrier J. Biol. Chem. 267 1992 25951 25957
8. F Denizot R Lang Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability J. Immunol. Methods 89 1986 271 277
9. P Gros Y.B Neriah J.M Croop D.E Housman Isolation and expression of a complementary DNA that confers multidrug resistance Nature 323 1986 728 731
10. A.K Gupta L.L Rocher S.P Schmaltz M.T Goldfarb M.D Brown C.N Ellis J.J Voorhees Short-term changes in renal function, blood pressure, and electrolytes levels in patients receiving cyclosporin for dermatologic disorders Arch. Intern. Med. 151 1991 356 362
11. D.V Hamilton D.B Evans R.G Henderson S Thiru R.Y Calne D.J.G White D.J.S Carmichael Nephrotoxicity and metabolic acidosis in transplant patients on cyclosporin A Proc. EDTA 18 1981 400 409
12. I.A Hauser M Koziolek U Hopfer F Thevenod Therapeutic concentrations of cyclosporin A, but not FK506, increase P -glycoprotein expression in endothelial and renal tubule cells Kidney Int. 54 1998 1139 11489
13. C.E Herzog M Tsokos S.E Bates A.T Fojo Increased mdr-1/ P -glycoprotein expression after treatment of human colon carcinoma cells with P -glycoprotein antagonists J. Biol. Chem. 268 1993 2946 2952
14. J Hinchey C Chaves B Appignani J Breen L Pao A Wang S.M Pessin G Lamy J.L Mas L.R Caplan A reversible posterior leukoencephalopathy syndrome N. Engl. J. Med. 334 1996 494 500
15. S.I Hsu L Lothstein S.B Horwitz Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells J. Biol. Chem. 264 1989 12053 12062
16. T.R Humphreys J.J Leyden Acute reversible central nervous system toxicity associated with low-dose oral cyclosporine therapy J. Am. Acad. Dermatol. 29 1993 490 492
17. L Jette E Beaulieu J.M Leclerc R Beliveau Cyclosporin A treatment induces overexpression of P -glycoprotein in the kidney and other tissues Am. J. Physiol. 270 1996 756 765
18. B.D Kahan Immunosuppressive therapy Curr. Opin. Immunol. 4 1992 553 560
19. A.I Lauerma C Surber H.I Maibach Absorption of topical tacrolimus (FK506) in vitro through human skin: comparison with cyclosporin A Skin Pharmacol. 10 1997 230 234
20. O Loreal A Fautrel B Meunier C Guyomard A Guillouzo B Launois FK506 is less cytotoxic than cyclosporine to human and rat hepatocytes in vitro Transplant Proc. 23 1991 2825 2828
21. O.H Lowry N.J Rosebrough A.L Farr R.J Randall Protein measurement with the folin phenol reagent J. Biol. Chem. 193 1951 265 275
22. F Massicot C Martin C.H Dutertre A.S Ellouk H.C Pham M Thevenin P Rucay J.M Warnet J.R Claude Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line Arch. Toxicol. 71 1997 529 531
23. G Mosieniak I Figiel B Kaminska Cyclosporin A, an immunosuppressive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor J. Neurochem. 68 1997 1142 1149
24. C Muller J.D Bailly F Goubin J Laredo J.P Jaffrezou C Bordier G Laurent Verapamil decreases P -glycoprotein expression in multidrug-resistant human leukemic cell lines Int. J. Cancer 56 1994 749 754
25. F Narasaki M Oka R Nakano K Ikeda M Fukuda T Nakamura H Soda M Nakagawa M Kuwano S Kohno Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells Biochem. Biophys. Res. Commun. 240 1997 606 611
26. I Postan M.C Willingham M.M Gottesman Molecular manipulations of the multidrug transporter: a new role of transgenic mice FABS J. 5 1991 2523 2528
27. R.L Powels H.M Clink D Spence G Morgenestern J.G Watson P.J Selby M Woods A Barret B Jameson J Sloane S.D Lawler H.E Kay D Lawson T.J McElwain P Alexander Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation Lancet 1 1980 327 329
28. M Rothenberg V Ling Multidrug resistance: molecular biology and clinical relevance J. Natl. Cancer Inst. 81 1989 907 910
29. C Shimizu S Kimura Y Yoshida A Nezu K Saitoh H Osaka Y Aihara Y Nagasaka Acute leucoencephalopathy during cyclosporin A therapy in a patient with nephrotic syndrome Pediatr. Nephrol. 8 1994 483 485
30. A Shirai M Naito T Tatsuta J Dong K Hanaoka K Mikami T Oh-hara T Tsuruo Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P -glycoprotein Biochem. Biophys. Acta 1222 1994 400 404
31. I Sugawara H Hamada T Tsuruo S Mori Specialized localization of P -glycoprotein recognized by MRK16 monoclonal antibody in endothelial cells of the brain and the spinal cord Jpn. J. Cancer Res. 81 1990 727 730
32. N Takeguchi K Ichimura M Koike W Matsui T Kashiwagura K Kawahara Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine Transplantation 55 1993 646 650
33. K Tanaka M Hirai Y Tanigawara M Yasuhara R Hori K Ueda K Inui Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P -glycoprotein Pharm. Res. 13 1996 1073 1077
34. T Tatsuta M Naito T Oh-hara I Sugawara T Tsuruo Functional involvement of P -glycoprotein in blood–brain barrier J. Biol. Chem. 267 1992 20383 20391
35. T Tatsuta M Naito K Mikami T Tsuruo Enhanced expression by the brain matrix of P -glycoprotein in brain capillary endothelial cells Cell Growth Differ. 5 1994 1145 1152
36. A Tsuji I Tamai A Sakata Y Tenda T Terasaki Restricted transport of cyclosporin A across the blood–brain barrier by a multidrug transporter P -glycoprotein Biochem. Pharmacol. 46 1993 1096 1099
37. F Worthmann T Turker A.R Muller S Patt G Stoltenburg-Didinger Progressive multifocal leucoencephalopathy after orthotopic liver transplantation Transplantation 57 1994 1268 1271
38. F Wrobewaki J.S La Due Lactic dehydrogenase activity in blood Proc. Soc. Exp. Biol. Med. 90 1955 210 213